marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Theravance Biopharma Cash Flow 2011-2024 | TBPH
Annual Cash Flow Theravance Biopharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-27 M | -187 M | -208 M | -250 M | -238 M | -113 M | -201 M | -99 M | -169 M | - | - | - | - |
Depreciation & Amortization |
1.9 M | 2.6 M | 3.5 M | 3.3 M | 3.3 M | 3.17 M | 4.03 M | 3.12 M | 2.99 M | 2.66 M | 2.65 M | 3.25 M | - |
Accounts Payables |
1.52 M | 1.55 M | 3.1 M | 6.78 M | 4.76 M | 9.03 M | 5.92 M | 1.73 M | 18.8 M | 9.92 M | - | - | - |
Accounts Receivables |
- | - | - | - | - | 620 K | 2.25 M | 646 K | 1.92 M | 289 K | - | - | - |
Total Inventories |
- | - | - | - | - | - | 16.8 M | 12.2 M | 10 M | 12.5 M | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Theravance Biopharma
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -1.02 M | - | - | - | -11.2 M | - | -62.9 M | -40.8 M | -26.1 M | - | -165 M | -120 M | -69.9 M | - | -185 M | -108 M | -55.1 M | - | -174 M | -129 M | -81.2 M | - | -60.7 M | -11.7 M | 49.8 M | - | -157 M | -94.6 M | -50 M | - | -70.9 M | -58.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.32 M | - | - | - | 1.01 M | - | 3.01 M | 2.06 M | 1.08 M | - | 1.94 M | 1.15 M | 699 K | - | 2.29 M | 1.57 M | 825 K | - | 2.49 M | 1.42 M | 732 K | - | 1.96 M | 1.4 M | 703 K | - | - | - | - | - | - | - | - |
Accounts Payables |
1.45 M | 1.67 M | 1.69 M | 1.52 M | 2.37 M | 1.57 M | 2.66 M | 1.55 M | 5.34 M | 3.07 M | 1.51 M | 3.1 M | 8.9 M | 10.7 M | 6.83 M | 6.78 M | 6.78 M | 6.78 M | 6.78 M | 4.76 M | 4.76 M | 4.76 M | 4.76 M | 9.03 M | 9.03 M | 9.03 M | 9.03 M | 5.92 M | 5.92 M | 5.92 M | 5.92 M | 1.73 M | 1.73 M | 1.73 M | 1.73 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 9.92 M | 9.92 M | 9.92 M | 9.92 M | 6.94 M | 6.94 M | 6.94 M | 6.94 M | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 87 K | 111 K | 113 K | 620 K | 620 K | 620 K | 620 K | 2.25 M | 2.25 M | 2.25 M | 2.25 M | 646 K | 646 K | 646 K | 646 K | 1.92 M | 1.92 M | 1.92 M | 1.92 M | 289 K | 289 K | 289 K | 289 K | 199 K | 199 K | 199 K | 199 K | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17.9 M | 17.9 M | 17.2 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 10 M | 10 M | 10 M | 10 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | - | - | - | - | - | - | - | - |
All numbers in USD currency